Ethnopharmacological relevance: Corydalis dubia is used in Bhutanese traditional medicine as a febrifuge and for treating infections in the blood, liver and bile which correlate to the signs and symptoms of malarial and microbial infections.
Introduction
Corydalis dubia Prain (Fumariaceae), which is locally known as Re-skon, is an annual yellowflowering glabrous herb of lower stature arising from tuberous rootstock. This plant is endemic to Bhutan, Sikkim (India) and Chumbi Valley of Tibet (Grierson and Long, 1984) . In Bhutan, it occurs in the wild in localized parts of Lingzhi and Bumthang region at an altitude range of 4294-5039 meters above sea level (Wangchuk et al., 2008; Anonymous, 2008) . It grows sparsely with recorded density of 0.6 to 3.6 plants/m 2 (Anonymous, 2008) . Therapeutic uses of this plant were reported for detoxifying impure blood, treating fever arising from the infections of liver, heart, lung, pancreas and kidney and alleviating neuralgia and complicated disorders that have resulted from a combination of defective air, bile and phlegm (Wangchuk et al., 2011) . These are symptoms which correlate to both malarial and microbial infections. A preliminary phytochemical screening demonstrated the presence of alkaloids and that the crude MeOH and CHCl 3 alkaloid extracts showed significant antiplasmodial activity against chloroquine and antifolate resistant Plasmodium falciparum strains: TM4/8.2 and K1CB1 (Wangchuk et al., 2011) . This prompted us to investigate the alkaloid constituents of C. dubia with a view to generate potential new therapeutic agents and at the same time validate the use of this plant in Bhutanese traditional medicine (BTM) for the treatment of malarial or microbial infections.
A systematic extraction and isolation protocol yielded one new natural product which we named as dubiamine (1) drawn from the species name of the plant. Seven known isoquinoline alkaloids were also isolated which were identified as scoulerine (2), cheilanthifoline (3), protopine (4), capnoidine (5), bicuculline (6), corydecumbine (7) and hydrastine (8). Compounds 1, 2, 5 and 6 were investigated for their antiplasmodial, antimicrobial and cytotoxicity activities. Compounds 2 showed significant antiplasmodial activity which is reported here for the first time. The antiplasmodial activities of compounds 3 and 4 were reported earlier by us and are included in Table 1 .
Materials and methods

Plant material
Wild C. dubia (whole part) was collected from Thruenchela ( 
Extraction, isolation and identification of alkaloids
The extraction and separation of the alkaloids from the crude methanol extract (65.12 g obtained from 2 kg dry plant material) was undertaken via an acid/base extraction procedure using the analytical chemicals and tools as reported in Wangchuk et al. (2012) . This protocol furnished the CH 2 Cl 2 extract (17.87 g) which contained a mixture of acidic and neutral compounds and the CHCl 3 extract (1.13 g) which contained the basic alkaloids. Focusing on the alkaloids, the CHCl 3 extract (1.2 g) was chromatographed on a silica gel (120 g, 200-300 mesh) column, eluting with a gradient solvent system of MeOH-CHCl 3 (total combined volume of 200 mL in a v/v ratio of 0:100, 0.5:99.5, 1.5:98.5, 3:97, 4:96, 5:95, 7:93, 10:90, 15:85, 20:80, 30:70, 40:60) gave compound 2 (9 mg). Crystallization of the sub-fraction F56.3 from CHCl 3 /MeOH (1:1) furnished compound 1 (7 mg). Fraction F7 was crystallized from the ethyl acetate/hexane (1:1) to give compound 4 (160 mg), the major alkaloid of the plant.
Compound 1 was identified as a new natural product which we named as dubiamine after the name of the plant species. (2) Cheilanthifoline (3) Protopine (4) Capnoidine ( (1) with CCDC 872799.
The structure of 1 (Fig. 1) was confirmed from the analysis of its single crystal X-ray crystallographic data ( While 1 has not been reported as a natural product, it has been synthesized in vitro from the enzymatic oxidation of d,l-N-norarmepavine which was assigned the IUPAC name as 4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)phenol (Inubushi et al., 1969) . This alkaloid was closely related to sendaverine and its derivatives (Pandey and Tiwari, 1980; Kametani and Ohkubo, 1965; Suau et al., 1994) . Other known compounds 2-8 were identified through MS library matching techniques (NIST08s) and subsequent comparison of their melting point, optical rotation, mass spectra and NMR spectra ( 1 H and 13 C) with those reported. Compound 2 was identified as scoulerine (Brochman-Hanssen and Nielson 1966; Cheng et al., 2008) , compound 3 as cheilanthifoline (Okamoto et al., 1971; Haisova and Slavik, 1973; Yeola and Mali, 1984; Rucker et al., 1994; Cheng et al., 2008) , compound 4 as protopine (Abou-Donia et al., 1980; Takahashi et al., 1985; Seger et al., 2004) , compound 5 as capnoidine Ribar and Meszaros, 1991; Pilar et al., 2010) whose structure was also confirmed from a X-ray crystal structure (not shown here), compound 6 as bicuculline (Edwards and Handa, 1961; Abou-Donia et al., 1980; Blasko et al., 1982; Elango, et al., 1982; Basha et al., 2002) , compound 7 as corydecumbine (Basnet et al., 1993) and compound 8 as hydrastine Elango, et al., 1982) .
Bioassay methods
Antiplasmodial, antimicrobial and cytotoxicity bioassays were carried out using the standard protocols reported by Wangchuk et al., (2011) . The test strains of Plasmodium falciparum used for the antiplasmodial assay were K1CB1, a multidrug resistant strain; and TM4/8.2, a wild type chloroquine and antifolate sensitive strain. Chloroquine, cycloguanil and pyrimethamine were used as reference drugs or positive controls in the antiplasmodial assays. DMSO (0.1%) and distilled water were used as controls to rule out the solvent effects on the bioassay results of the test samples. All the experiments were performed three times in duplicate (3x2).
Results and Discussions
Given the traditional use of C. dubia to treat fever and various disorders bearing relevance to malaria and microbial infections and the evidence that the crude alkaloid extracts exhibited significant antiplasmodial activity (Wangchuk et al., 2011) , we investigated the bioactive alkaloid constituents of this plant. Out of eight alkaloids (compounds 1-8, Fig. 1 ) isolated from this plant, we examined compounds 1, 2, 5 and 6 for their antiplasmodial, cytotoxicity and antimicrobial and activities (Table   1) .
Table 1
Antiplasmodial activity (IC 50 in μg/mL) of the pure compounds 1, 2, 5 and 6 isolated from C. dubia. Interestingly, compound 2 demonstrated significant in vitro antiplasmodial activity against the P. falciparum strains: TM4/8.2 (a wild type chloroquine and antifolate sensitive strain) and K1CB1 (multidrug resistant strain) with IC 50 values of 1.78 µg/mL (5.47 μM) and 1.04 µg/mL (3.1 μM), respectively. Compounds 3 and 4 were isolated from different plant species and their antiplasmodial activities were determined earlier by us (Wangchuk et al., 2010; Wangchuk et al., 2012) and are included in this study (Table 1) . Compounds 2, 3, and 4 exhibited similar antiplasmodial activity.
However, the activities of compound 2 were found to be almost two fold better than the CHCl 3 crude alkaloid extract (2.21 and 2.84 µg/mL against TM4/8.2 and K1CB1 strains, respectively); seven fold Scoulerine (2) 1.78 ± 0.72 1.04 ± 0.08 >20 >20
Cheilanthifoline ( better than the crude MeOH extract (6.38 µg/mL for TM4/8.2 and 9.50 µg/mL for K1CB1 strains); and eight fold better than the conventional antimalarial drug pyrimethamine (reference drug) against the K1CB1 strain (Table 1) . Although the antiplasmodial activity of scoulerine (2) does not meet the criteria of the medicines for malaria venture (MMV), it represents a potential new scaffold based on which the improved antimalarial lead compounds can be drawn, particularly as it did not show mammalian cell line (KB and Vero cells) toxicity (Table 1 ) and has not been previously reported.
Scoulerine has been reported to exhibit other activities such as: anti-topoisomerase I (Cheng et al., 2008) , GABA A receptor agonist (Eisenreich et al., 2003) , and antiemetic, antitussive and antibacterial activities (Taylor and Francis, 2011) .
Compounds 1, 5 and 6 did not show antiplasmodial activity even at the highest tested concentration of 10-20 μM. Due to the smaller quantities of compounds 7 and 8, their biological activity studies were not carried out.
Since compounds 2, 3 and 4 have shown significant antiplasmodial activities and that protopine (4) was the major alkaloid present, it may be deduced that these three alkaloids (alone or 
Conclusions and future directions
In summary, our study found the following: a) a new natural product (1) was isolated which we named as dubiamine and its structure was confirmed from its single crystal X-ray structure b)
compound 2 showed significant in vitro antiplasmodial activity without mammalian cell toxicity and was identified as a potential antimalarial hit scaffold c) the in vitro antiplasmodial activity of the crude extracts and the pure compounds 2, 3 and 4 is commensurated with the ethnopharmacological uses of this plant and thus substantiated its usage in BTM for the aforementioned disorders. However, it may be premature to claim that the plant extract formulated and administrated according to traditional protocols would be safe and effective for treating humans. Therefore, in vivo animal model of malaria using methods of traditional preparation and administration would more confidently support the use of the plants in treating humans. As resistance to the front line antimalarial drug, artesunate, appears to be emerging (Dondorp et al., 2009) , the above in vivo experiments on crude extracts and also on compound 2, 3 and 4 which showed significant antiplasmodial activity against antifolate sensitive and multidrug resistant strains are essential and will be possibly carried out in future.
